113 related articles for article (PubMed ID: 6540099)
1. [Animal experimental studies on the pharmacology of a new anti-arrhythmic of the imino-cycloheptane series, stirocainide].
Borchard U; Dénes B; Greeff K
Arzneimittelforschung; 1984; 34(4):416-22. PubMed ID: 6540099
[TBL] [Abstract][Full Text] [Related]
2. Effects of a new antiarrhythmic compound [2-benzal-1-(2' diisopropyl-amino-ethoxy-imino)-cycloheptane hydrogen fumarate] on the electrophysiological properties of mammalian cardiac cells.
Rüdiger HJ; Homburger H; Antoni H
Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):238-44. PubMed ID: 6275279
[TBL] [Abstract][Full Text] [Related]
3. Electrophysiological and antiarrhythmic actions of tocainide in isolated heart preparations of the guinea pig.
Borchard U; Hafner D; Ewerbeck S
Arzneimittelforschung; 1985; 35(9):1367-74. PubMed ID: 3936506
[TBL] [Abstract][Full Text] [Related]
4. Investigations into the bradycardic action of indoramin.
Lillie C; Harron DW; Kobinger W
Arzneimittelforschung; 1985; 35(1A):301-5. PubMed ID: 4039170
[TBL] [Abstract][Full Text] [Related]
5. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
Carmeliet E; Janssen PA; Marsboom R; Van Nueten JM; Xhonneux R
Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
[TBL] [Abstract][Full Text] [Related]
6. Characterization of antiarrhythmic drugs by alternating current induced arrhythmias in isolated heart tissues.
Borchard U; Bösken R; Greeff K
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):253-68. PubMed ID: 6125132
[TBL] [Abstract][Full Text] [Related]
7. [Anti-arrhythmic mechanisms of sophoramine].
Yao JA; Zhang BH
Zhongguo Yao Li Xue Bao; 1989 Jul; 10(4):315-9. PubMed ID: 2624114
[TBL] [Abstract][Full Text] [Related]
8. Hypotensive and antiarrhythmic effects of a new alkaloid, the 13-hydroxylupanine-2-pyrrolcarbonic acid ester, from the Madagascan plant Cadia ellisiana.
Lindner E; Kaiser J; Schacht U
Arzneimittelforschung; 1976; 26(9):1651-7. PubMed ID: 11808
[TBL] [Abstract][Full Text] [Related]
9. Action potential, membrane currents and force of contraction in mammalian heart muscle fibers treated with quinidine.
Nawrath H
J Pharmacol Exp Ther; 1981 Jan; 216(1):176-82. PubMed ID: 7452504
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacology of 2'-[2-hydroxy-3-(propylamino)-propoxy]-3-phenylpropiophenone (Propafenone, SA 79)-hydrochloride].
Hapke HJ; Prigge E
Arzneimittelforschung; 1976; 26(10):1849-57. PubMed ID: 1037204
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
12. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiological characterization of class III activity of a verapamil derivative in guinea-pig cardiac tissues.
Kammer T; Berger F; Borchard U; Hafner D
Arzneimittelforschung; 1993 Mar; 43(3):302-8. PubMed ID: 8489557
[TBL] [Abstract][Full Text] [Related]
14. In vitro cardiac effects and antiarrhythmic properties of guanfacine.
Scholtysik G; Brugger P
Arzneimittelforschung; 1989 Apr; 39(4):450-4. PubMed ID: 2665757
[TBL] [Abstract][Full Text] [Related]
15. Effects of purified endogenous inhibitor of the Na+/Ca2+ exchanger on ouabain-induced arrhythmias in the atria and ventricle strips of guinea pig.
Shpak B; Gofman Y; Shpak C; Hiller R; Boyman L; Khananshvili D
Eur J Pharmacol; 2006 Dec; 553(1-3):196-204. PubMed ID: 17078946
[TBL] [Abstract][Full Text] [Related]
16. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations.
Beresewicz A; Pytkowski B; Sedek G; Zdanowski K
Pol J Pharmacol Pharm; 1983; 35(3):223-32. PubMed ID: 6651921
[TBL] [Abstract][Full Text] [Related]
17. Effects of gallium chloride on changes in action potentials and contraction in guinea pig ventricular muscle.
Kantelip JP; Millart H; Leperre A; Mougin F; Didier JM
Anticancer Res; 1996; 16(1):327-32. PubMed ID: 8615630
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic and electrophysiological actions of flecainide, bepridil and amiodarone on isolated heart preparations during controlled hypoxia.
Dietrich H; Borchard U; Hafner D; Hirth C
Arch Int Pharmacodyn Ther; 1985 Apr; 274(2):267-82. PubMed ID: 3875326
[TBL] [Abstract][Full Text] [Related]
19. [Action of fomocaine on heart and circulation (author's transl)].
Reuter N; Meyer F; Ziegenmeyer J; Bock M
Arzneimittelforschung; 1975; 25(12):1900-6. PubMed ID: 1243660
[TBL] [Abstract][Full Text] [Related]
20. Cardiac electrophysiologic and antiarrhythmic actions of 3,4-dihydro-1'-[2-(benzofurazan-5-yl) ethyl]-6-methanesulfonamidospiro [(2H)-1-benzopyran-2,4'-piperidin]-4-one HCl (L-691,121), a novel class III agent.
Lynch JJ; Wallace AA; Van der Gaag LH; Baskin EP; Bear CM; Gehret JR; Kothstein T; Stupienski RF; Appleby SD; Sanguinetti MC
J Pharmacol Exp Ther; 1993 May; 265(2):720-30. PubMed ID: 8496818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
